Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGSWW) Cash & Current Investments (2020 - 2025)

GeneDx Holdings has reported Cash & Current Investments over the past 6 years, most recently at $171.3 million for Q4 2025.

  • Quarterly results put Cash & Current Investments at $171.3 million for Q4 2025, up 21.32% from a year ago — trailing twelve months through Dec 2025 was $171.3 million (up 21.32% YoY), and the annual figure for FY2025 was $171.3 million, up 21.32%.
  • Cash & Current Investments for Q4 2025 was $171.3 million at GeneDx Holdings, up from $155.1 million in the prior quarter.
  • Over the last five years, Cash & Current Investments for WGSWW hit a ceiling of $461.3 million in Q3 2021 and a floor of $26.5 million in Q2 2021.
  • Median Cash & Current Investments over the past 5 years was $148.1 million (2024), compared with a mean of $178.7 million.
  • Biggest five-year swings in Cash & Current Investments: skyrocketed 40363.55% in 2021 and later tumbled 69.06% in 2022.
  • GeneDx Holdings' Cash & Current Investments stood at $400.6 million in 2021, then tumbled by 69.06% to $123.9 million in 2022, then rose by 5.01% to $130.1 million in 2023, then grew by 8.48% to $141.2 million in 2024, then grew by 21.32% to $171.3 million in 2025.
  • The last three reported values for Cash & Current Investments were $171.3 million (Q4 2025), $155.1 million (Q3 2025), and $134.6 million (Q2 2025) per Business Quant data.